Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Aneurysm, Abdominal | 8 | 2002 | 120 | 0.560 |
Why?
|
Blood Vessel Prosthesis | 14 | 1998 | 242 | 0.480 |
Why?
|
Aortic Aneurysm | 9 | 2002 | 80 | 0.460 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2002 | 226 | 0.450 |
Why?
|
Aortic Rupture | 5 | 2002 | 57 | 0.380 |
Why?
|
Aorta, Abdominal | 12 | 1995 | 59 | 0.310 |
Why?
|
Postoperative Complications | 16 | 2002 | 2275 | 0.300 |
Why?
|
Stents | 2 | 2002 | 395 | 0.190 |
Why?
|
Cerebrovascular Disorders | 4 | 1994 | 143 | 0.190 |
Why?
|
Iliac Aneurysm | 1 | 2001 | 8 | 0.190 |
Why?
|
Coronary Artery Bypass | 2 | 1993 | 234 | 0.180 |
Why?
|
Leg | 7 | 1995 | 140 | 0.160 |
Why?
|
Follow-Up Studies | 15 | 2002 | 3657 | 0.160 |
Why?
|
Vascular Surgical Procedures | 3 | 2002 | 149 | 0.160 |
Why?
|
Intestinal Fistula | 4 | 1988 | 31 | 0.150 |
Why?
|
Coronary Disease | 3 | 2001 | 260 | 0.150 |
Why?
|
Saphenous Vein | 3 | 1991 | 61 | 0.120 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 1993 | 51 | 0.110 |
Why?
|
Chylous Ascites | 1 | 1993 | 9 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 5 | 2001 | 2657 | 0.110 |
Why?
|
Protein C Deficiency | 1 | 1993 | 4 | 0.110 |
Why?
|
Thrombophlebitis | 1 | 1993 | 25 | 0.110 |
Why?
|
Diabetic Angiopathies | 3 | 1993 | 37 | 0.110 |
Why?
|
Aortic Diseases | 5 | 1995 | 100 | 0.110 |
Why?
|
Carotid Arteries | 3 | 1990 | 127 | 0.100 |
Why?
|
Thrombectomy | 2 | 1995 | 172 | 0.100 |
Why?
|
Endarterectomy | 3 | 1995 | 20 | 0.100 |
Why?
|
Arteries | 4 | 1989 | 180 | 0.100 |
Why?
|
Aged | 19 | 2002 | 19078 | 0.100 |
Why?
|
Cause of Death | 1 | 1993 | 266 | 0.100 |
Why?
|
Thrombolytic Therapy | 2 | 1995 | 232 | 0.100 |
Why?
|
Lipid Peroxidation | 1 | 1991 | 44 | 0.100 |
Why?
|
Time Factors | 10 | 2002 | 5320 | 0.090 |
Why?
|
Premedication | 2 | 1988 | 58 | 0.090 |
Why?
|
Fistula | 4 | 1988 | 42 | 0.090 |
Why?
|
Arterial Occlusive Diseases | 5 | 1995 | 109 | 0.090 |
Why?
|
Femoral Artery | 3 | 1998 | 83 | 0.080 |
Why?
|
Venous Pressure | 1 | 1988 | 11 | 0.080 |
Why?
|
Venous Insufficiency | 1 | 1988 | 12 | 0.080 |
Why?
|
Iliac Vein | 1 | 1988 | 30 | 0.080 |
Why?
|
Prosthesis Failure | 2 | 2001 | 116 | 0.080 |
Why?
|
Reoperation | 4 | 2001 | 598 | 0.080 |
Why?
|
Femoral Vein | 1 | 1988 | 39 | 0.080 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 1988 | 3 | 0.080 |
Why?
|
Intermittent Claudication | 1 | 1988 | 20 | 0.080 |
Why?
|
Ischemia | 5 | 1995 | 251 | 0.080 |
Why?
|
Prosthesis Design | 2 | 2001 | 296 | 0.080 |
Why?
|
Appendix | 1 | 1988 | 31 | 0.080 |
Why?
|
Male | 25 | 2002 | 42254 | 0.080 |
Why?
|
Humans | 38 | 2002 | 89073 | 0.080 |
Why?
|
Middle Aged | 21 | 2002 | 25865 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 1992 | 362 | 0.070 |
Why?
|
Cephalosporins | 1 | 1987 | 24 | 0.070 |
Why?
|
Incidence | 4 | 2001 | 1592 | 0.070 |
Why?
|
Female | 22 | 2002 | 46014 | 0.070 |
Why?
|
Length of Stay | 2 | 2001 | 732 | 0.070 |
Why?
|
Vascular Diseases | 1 | 1987 | 118 | 0.070 |
Why?
|
Polytetrafluoroethylene | 3 | 1995 | 74 | 0.060 |
Why?
|
Blood Transfusion, Autologous | 1 | 1984 | 16 | 0.060 |
Why?
|
Survival Rate | 2 | 2002 | 1889 | 0.060 |
Why?
|
Heart Transplantation | 3 | 1994 | 717 | 0.050 |
Why?
|
Endoscopy | 1 | 1986 | 348 | 0.050 |
Why?
|
Aorta | 3 | 1991 | 288 | 0.050 |
Why?
|
Staphylococcal Infections | 2 | 1987 | 269 | 0.050 |
Why?
|
Popliteal Artery | 3 | 1994 | 28 | 0.050 |
Why?
|
Catheterization | 3 | 1995 | 237 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2001 | 8203 | 0.050 |
Why?
|
Angioplasty | 1 | 2001 | 70 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2001 | 135 | 0.050 |
Why?
|
Equipment Design | 1 | 2002 | 415 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 2 | 1995 | 99 | 0.050 |
Why?
|
Morbidity | 1 | 2001 | 149 | 0.050 |
Why?
|
Blood Loss, Surgical | 1 | 2001 | 115 | 0.040 |
Why?
|
Radiography | 2 | 2001 | 809 | 0.040 |
Why?
|
Population Surveillance | 1 | 2001 | 216 | 0.040 |
Why?
|
Ultrasonography | 3 | 1994 | 711 | 0.040 |
Why?
|
Hemodynamics | 3 | 1994 | 729 | 0.040 |
Why?
|
Risk Factors | 5 | 1998 | 5466 | 0.040 |
Why?
|
Retroperitoneal Fibrosis | 1 | 1978 | 6 | 0.040 |
Why?
|
Prospective Studies | 7 | 1995 | 4273 | 0.040 |
Why?
|
Research Design | 1 | 2002 | 597 | 0.040 |
Why?
|
Adult | 11 | 1995 | 26508 | 0.040 |
Why?
|
Intraoperative Complications | 2 | 1998 | 188 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 1995 | 6777 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2002 | 1855 | 0.040 |
Why?
|
Bacterial Infections | 2 | 1989 | 184 | 0.040 |
Why?
|
Comorbidity | 1 | 2001 | 948 | 0.040 |
Why?
|
Hospital Costs | 1 | 1998 | 107 | 0.040 |
Why?
|
Forecasting | 1 | 1998 | 305 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 2 | 1993 | 36 | 0.030 |
Why?
|
Clinical Trials as Topic | 3 | 1998 | 1149 | 0.030 |
Why?
|
Endarterectomy, Carotid | 1 | 1994 | 75 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 1994 | 197 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 1993 | 41 | 0.030 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1993 | 14 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 1994 | 115 | 0.030 |
Why?
|
Analysis of Variance | 1 | 1995 | 901 | 0.030 |
Why?
|
Diuretics | 1 | 1993 | 75 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 1995 | 1710 | 0.030 |
Why?
|
Peripheral Vascular Diseases | 1 | 1992 | 61 | 0.030 |
Why?
|
Angiography | 1 | 1993 | 208 | 0.030 |
Why?
|
Iliac Artery | 2 | 1984 | 38 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 1993 | 434 | 0.030 |
Why?
|
Heparin | 1 | 1993 | 185 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 1993 | 159 | 0.030 |
Why?
|
Lipid Peroxides | 1 | 1991 | 11 | 0.020 |
Why?
|
Phospholipids | 1 | 1991 | 111 | 0.020 |
Why?
|
Triglycerides | 1 | 1991 | 232 | 0.020 |
Why?
|
Hypertension | 2 | 1993 | 741 | 0.020 |
Why?
|
Cefamandole | 1 | 1989 | 1 | 0.020 |
Why?
|
Cefazolin | 1 | 1989 | 7 | 0.020 |
Why?
|
Retrospective Studies | 7 | 1995 | 9003 | 0.020 |
Why?
|
Elastic Tissue | 1 | 1989 | 18 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 1988 | 786 | 0.020 |
Why?
|
Coronary Vessels | 1 | 1991 | 190 | 0.020 |
Why?
|
Cholesterol | 1 | 1991 | 357 | 0.020 |
Why?
|
United States | 2 | 2001 | 6957 | 0.020 |
Why?
|
Smoking | 1 | 1993 | 620 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2001 | 42 | 0.020 |
Why?
|
Intraoperative Period | 2 | 1989 | 90 | 0.020 |
Why?
|
Cecal Diseases | 1 | 1988 | 5 | 0.020 |
Why?
|
Polyethylene Terephthalates | 1 | 1988 | 18 | 0.020 |
Why?
|
Jugular Veins | 1 | 1988 | 74 | 0.020 |
Why?
|
Laparotomy | 1 | 1988 | 67 | 0.020 |
Why?
|
Thromboembolism | 1 | 1989 | 120 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 1988 | 60 | 0.020 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 1988 | 71 | 0.020 |
Why?
|
Dogs | 1 | 1988 | 704 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 1988 | 273 | 0.020 |
Why?
|
Arizona | 1 | 1986 | 10 | 0.020 |
Why?
|
Evaluation Studies as Topic | 3 | 1995 | 270 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 1989 | 214 | 0.020 |
Why?
|
Postoperative Care | 2 | 1994 | 229 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1986 | 120 | 0.020 |
Why?
|
Thrombosis | 1 | 1989 | 302 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2002 | 1837 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1988 | 237 | 0.020 |
Why?
|
Venae Cavae | 1 | 1984 | 13 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 1984 | 43 | 0.010 |
Why?
|
Aneurysm | 1 | 1984 | 60 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1984 | 153 | 0.010 |
Why?
|
Recurrence | 1 | 1986 | 1140 | 0.010 |
Why?
|
Adolescent | 2 | 1995 | 9237 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1988 | 2362 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2001 | 69 | 0.010 |
Why?
|
Staphylococcus | 1 | 1980 | 24 | 0.010 |
Why?
|
Duodenal Diseases | 1 | 1980 | 23 | 0.010 |
Why?
|
Preoperative Care | 2 | 1994 | 396 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1979 | 112 | 0.010 |
Why?
|
Ureteral Diseases | 1 | 1978 | 14 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 1980 | 201 | 0.010 |
Why?
|
Ureteral Obstruction | 1 | 1978 | 67 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1980 | 275 | 0.010 |
Why?
|
Angioscopes | 1 | 1995 | 1 | 0.010 |
Why?
|
Aneurysm, Ruptured | 1 | 1995 | 54 | 0.010 |
Why?
|
Vascular Patency | 1 | 1995 | 126 | 0.010 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 1994 | 38 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 1994 | 55 | 0.010 |
Why?
|
Running | 1 | 1994 | 25 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2001 | 1043 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 1994 | 68 | 0.010 |
Why?
|
Random Allocation | 2 | 1986 | 328 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1994 | 182 | 0.010 |
Why?
|
Hypertriglyceridemia | 1 | 1992 | 68 | 0.010 |
Why?
|
Stroke Volume | 1 | 1994 | 462 | 0.010 |
Why?
|
Critical Illness | 1 | 1994 | 306 | 0.010 |
Why?
|
Exercise | 1 | 1994 | 322 | 0.010 |
Why?
|
Cardiac Output | 1 | 1991 | 156 | 0.010 |
Why?
|
Sex Factors | 1 | 1994 | 1063 | 0.010 |
Why?
|
Serum Bactericidal Test | 1 | 1989 | 1 | 0.010 |
Why?
|
Streptokinase | 1 | 1989 | 12 | 0.010 |
Why?
|
Animals | 1 | 1988 | 27324 | 0.010 |
Why?
|
Postoperative Period | 1 | 1990 | 301 | 0.010 |
Why?
|
Logistic Models | 1 | 1992 | 1212 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 1991 | 264 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1990 | 162 | 0.000 |
Why?
|
Bioprosthesis | 1 | 1988 | 39 | 0.000 |
Why?
|
Specimen Handling | 1 | 1988 | 102 | 0.000 |
Why?
|
Acute Disease | 1 | 1990 | 841 | 0.000 |
Why?
|
Intestine, Small | 1 | 1988 | 299 | 0.000 |
Why?
|
Hemorrhage | 1 | 1988 | 278 | 0.000 |
Why?
|
Inguinal Canal | 1 | 1986 | 6 | 0.000 |
Why?
|
Actuarial Analysis | 1 | 1986 | 66 | 0.000 |
Why?
|
Leg Ulcer | 1 | 1985 | 7 | 0.000 |
Why?
|
Transplantation, Autologous | 1 | 1986 | 343 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1994 | 3443 | 0.000 |
Why?
|